Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A common solution to group 2 influenza virus neutralization

11 Dec 2013

Abstract excerpt

The discovery and characterization of broadly neutralizing antibodies (bnAbs) against influenza viruses have raised hopes for the development of monoclonal antibody (mAb)-based immunotherapy and the design of universal influenza vaccines. Only one human bnAb (CR8020) specifically recognizing group 2 influenza A viruses has been previously characterized that binds to a highly conserved epitope at the base of the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Influenza Virus Research Studies
Share to Monoclonal and Polyclonal Antibodies Research
Share to Respiratory viral infections research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24335589
DOI: 10.1073/pnas.1319058110

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A common solution to group 2 influenza virus neutralizationPMID 24335589Read ↗

A highly conserved neutralizing epitope on group 2 influenza A viruses.Semantic proximity Read ↗

A Broadly Neutralizing Human Monoclonal Antibody That Recognizes a Conserved, Novel Epitope on the Globular Head of the Influenza H1N1 Virus HemagglutininSemantic proximity Read ↗

Human protective monoclonal antibodies against the HA stem of group 2 HAs derived from an H3N2 virus-infected human.Semantic proximity Read ↗

The influenza hemagglutinin stem antibody CR9114: Evidence for a narrow evolutionary path towards universal protectionSemantic proximity Read ↗

Identification of a cross-neutralizing antibody that targets the receptor binding site of H1N1 and H5N1 influenza virusesSemantic proximity Read ↗

Structurally convergent antibodies derived from different vaccine strategies target the influenza virus HA anchor epitope with a subset of VH3 and VK3 genesSemantic proximity Read ↗

A multimechanistic antibody targeting the receptor binding site potently cross-protects against influenza B virusesSemantic proximity Read ↗

A broadly neutralizing antibody recognizes a unique epitope with a signature motif common across coronavirusesSemantic proximity Read ↗

Antibody 27F3 Broadly Targets Influenza A Group 1 and 2 Hemagglutinins through a Further Variation in VH1-69 Antibody Orientation on the HA Stem.Semantic proximity Read ↗

Vulnerability in the breadth evolution of an influenza broadly neutralizing antibodySemantic proximity Read ↗

Structure of a Classical Broadly Neutralizing Stem Antibody in Complex with a Pandemic H2 Influenza Virus HemagglutininSemantic proximity Read ↗

Membrane-anchored influenza neuraminidase vaccine drives human-like broadly protective B cell responsesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.